Closed Thread
Page 1 of 20 1234511 ... LastLast
Results 1 to 10 of 196
Nicotine absorbtion from vaping research in Electronic Cigarette Research; I've been in touch with: Thomas Eissenberg, Ph .D. Professor of Psychology Institute for Drug and Alcohol Studies Virginia Commonwealth ...
  1. #1
    Moved On
    Join Date
    Jun 2008
    Location
    UK
    Posts
    7,233

    Arrow Nicotine absorbtion from vaping research

    I've been in touch with:

    Thomas Eissenberg, Ph.D.
    Professor of Psychology
    Institute for Drug and Alcohol Studies
    Virginia Commonwealth University

    Dr Eissenberg sent me a message today after his return from a conference in Ireland. As he is conducting research on blood nicotine levels with vaping I had asked him for some results. He doesn't have any himself yet but said Ruyan's team came up with this:

    "... Bullen, Glover, Laugesen, Lin, McRobbie, and Thornley report that after 9 participants used the Ruyan device (16 mg cartridge) for 5 minutes, peak plasma nicotine concentration was 1.3 ng/ml (95% confidence interval = 0.0 to 2.6). In contrast, for those same participants, a cigarette produced a peak plasma nicotine concentration of 13.4 ng/ml (95% CI = 6.5-20)."

    Then he went on to say:

    "These data, if they are valid and can be replicated, provide little support to the manufacturers' claim that the devices can do what they are marketed to do: deliver a physiologically active nicotine dose to the lung.
    "

    I am glad that we now have the first statistics on actual absorption of nicotine from vaping. This result is surprising to me though, it appears that 16mg nicotine eliquid gives a tenth of the nicotine to the bloodstream after five minutes vaping as a cigarette.

  2. Advertisement
  3. #2
    PV Master ECF Veteran
    Join Date
    Mar 2009
    Location
    UK
    Posts
    3,054

    Default

    Hi Kate,

    I am glad that we now have the first statistics on actual absorption of nicotine from vaping. This result is surprising to me though, it appears that 16mg nicotine eliquid gives a tenth of the nicotine to the bloodstream after five minutes vaping as a cigarette
    Are you able to say how this might affect our ideas on estimating equivalency of dose when switching over to vaping from smoking?

    C.

  4. #3
    Super Member ECF Veteran blueeyekelly's Avatar
    Join Date
    Apr 2009
    Location
    all ove the USA
    Posts
    693

    Default

    Again who said it is the nicotine that us smokers are actully after?

  5. #4
    Moved On
    Join Date
    Jun 2008
    Location
    UK
    Posts
    7,233

    Default

    This throws all our current comparisons off track C., I don't know what we can say about this for swappers.

    I don't even know how it's possible that many of us have been able to overdose if these figures are reliable.

  6. #5
    PV Master ECF Veteran
    Join Date
    Mar 2009
    Location
    UK
    Posts
    3,054

    Default

    Quote Originally Posted by Kate View Post
    This throws all our current comparisons off track C., I don't know what we can say about this for swappers.

    I don't even know how it's possible that many of us have been able to overdose if these figures are reliable.
    There may be significant differences between absorption via lung tissue and absorption via the mouth - I suggest that because I certainly do not draw in vapor as deep as I used to draw in smoke. Perhaps the route travelled by nicotine or other chemicals is longer via the lungs.

    I guess this means that paying close attention to one's reactions is more important than arithmetical calculations to determine input, especially where input varies so much depending on how the vaper inhales.

    I think I read somewhere that Yale are also engaged on this type of research for Next Safety. I don't suppose they will be disclosing their findings, though.

    Adding the source in edit;

    http://www.nextsafety.com/

    extract:
    Start quote:
    Next Safety has particularly shown that its pulmonary devices deliver nicotine with a far greater efficacy than other nicotine replacement products. While previous nicotine replacement products, such as nicotine gum and patches (a $1.6 billion global market), have helped millions of smokers worldwide, they cannot equal the power of nicotine that is delivered through an actual smoked cigarette. The result is that most smokers succumb to the need for a ‘nicotine hit’ by smoking again.

    The ultimate solution in nicotine replacement treatment would therefore be the rapid delivery of nicotine directly to the lungs and brain in the same manner as a cigarette, but without the 4,000 harmful chemicals that exist in tobacco particles.

    Cigarette sales in 2006 exceeded $200 billion in developed countries where strong trends to eliminate smoking inside work establishments and all public areas are firmly entrenched. Moreover, Next Safety projects that the cost of nicotine delivered by its pulmonary devices will be between 5% to 10% of the price currently paid by smokers in the United States for an equivalent blood nicotine dose.

    Next Safety’s ongoing applied research program is currently focused on the pulmonary delivery of nicotine, albuterol and tobramycin. Yale University and the Company’s tobacco addiction/cessation expert, Matthew Bars (MS, CTTS), director of Smoking Cessation for the New York Fire Department, are currently engaged in the development of a research protocol aimed at demonstrating the lung and brain uptake of nicotine from Next Safety’s pulmonary drug delivery platform. In addition, the Veterans Administration has asked Next Safety to participate in a study that includes the evaluation of inhaled nicotine utilizing the Company’s devices. This research will use various analytical techniques including certain brain imaging technology to study the effects of “clean” nicotine delivery via the Company’s pulmonary drug delivery platform.

    Next Safety believes the sale of the business to a leading pharmaceutical company will accelerate the deployment of this new technology. Large pharmaceutical firms possess the necessary expertise and development, manufacturing and distribution capabilities required to optimize current present value of Next Safety technology, while bringing lifesaving technology to market in a rapid and worldwide manner. End quote.

    Seems like a similar aim for the research...perhaps a different outcome though..

    C
    Last edited by Caesarea; 05-01-2009 at 10:29 PM.

  7. #6
    Super Member
    Join Date
    Mar 2009
    Location
    Biloxi, MS
    Posts
    419

    Default

    I think it's possible, because I don't think very many people vape the way they smoke. I certainly don't. I take many more drags off my ecigs then I ever took off of my regular cigs per day. I think you'd have to find a way to measure this over a longer stretch of time in order to get valid data.

  8. #7
    PV Master ECF Veteran
    Join Date
    Jan 2008
    Location
    Port Charlotte, FL USA
    Posts
    5,624

    Default

    This correlates well with my personal experience. I still get nothing remotely resembling a cigarette nic hit when vaping 36mg liquid. Dr. Loi wrote me in an email that he uses 40mg liquid. I calculated I'd need at least 80mg to be satisfied -- but the liquid would be too dangerous to even handle!

    Many thanks for your efforts, Kate. I know they were unexpected by you, based on prior posts. For me, I do know that when I combine heavy nicotine snus with e-smoking, I do just fine. I like the feel and visuals of e-smoking too much to want to give it up. But I get more nic from the snus.

  9. #8
    PV Master ECF Veteran
    Join Date
    Mar 2009
    Location
    UK
    Posts
    3,054

    Default

    Quote Originally Posted by Skad View Post
    I think it's possible, because I don't think very many people vape the way they smoke. I certainly don't. I take many more drags off my ecigs then I ever took off of my regular cigs per day. I think you'd have to find a way to measure this over a longer stretch of time in order to get valid data.
    Hi Skad,
    Do you inhale the vapor as deeply as when you were smoking?
    When I vape, the vapor is circulating mainly around the soft palate and the nasal passages, and often reminds me of how I used to smoke a pipe when I was a student. Much puffing and sucking but really quite little deep inhalation.

    C.

  10. #9
    PV Master ECF Veteran
    Join Date
    Jan 2008
    Location
    Port Charlotte, FL USA
    Posts
    5,624

    Default

    One more thought, based on this quote:

    "These data, if they are valid and can be replicated, provide little support to the manufacturers' claim that the devices can do what they are marketed to do: deliver a physiologically active nicotine dose to the lung."
    One of the FDA's definitions of a drug, which they claim e-liquid is, is that it produces a psychological and physiological effect. Ha. I get neither -- and these tests bring into question whether the effect is any greater than a placebo or pure PG would provide. Some manufacturer might turn this to their advantage, claiming e-liquid does NOT meet the definition of a drug as presently constituted.

  11. #10
    Super Member
    Join Date
    Mar 2009
    Location
    Biloxi, MS
    Posts
    419

    Default

    Quote Originally Posted by Caesarea View Post
    Hi Skad,
    Do you inhale the vapor as deeply as when you were smoking?
    When I vape, the vapor is circulating mainly around the soft palate and the nasal passages, and often reminds me of how I used to smoke a pipe when I was a student. Much puffing and sucking but really quite little deep inhalation.

    C.
    Indeed, I use more of a pipe/cigar style inhale as opposed to a cig inhale.

Closed Thread
Page 1 of 20 1234511 ... LastLast

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

SEO by vBSEO